quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:21:38·90d
ANALYSTRating
vTv Therapeutics Inc. logo

Roth Capital initiated coverage on vTv Therapeutics with a new price target

VTVT· vTv Therapeutics Inc.
Health Care
Original source

Companies

  • VTVT
    vTv Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Mar 12UpdateEvercore ISI$44.00
  • Jan 23UpdateRoth Capital$58.00
  • Jan 5UpdateTD Cowen$67.00
  • Nov 19UpdateBTIG Research$40.00
  • Feb 18UpdateCantor Fitzgerald$5.00

Related

  • SEC7d
    Amendment: SEC Form SCHEDULE 13G/A filed by vTv Therapeutics Inc.
  • PR16d
    vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
  • SEC27d
    SEC Form SCHEDULE 13G filed by vTv Therapeutics Inc.
  • PR39d
    vTv Therapeutics to Participate in the 38th Annual ROTH Conference
  • ANALYST42d
    Evercore ISI initiated coverage on vTv Therapeutics with a new price target
  • SEC44d
    vTv Therapeutics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
  • SEC44d
    vTv Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • SEC44d
    SEC Form 10-K filed by vTv Therapeutics Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022